
Image Source: unsplash
The artificial intelligence (AI) wave resonates with industrial recovery, driving the Hong Kong stock market to exhibit a bull market pattern in 2026. Market opportunities are expected to feature structural characteristics rather than a broad rally. Some mainstream investment banks have expressed optimistic expectations, for example, Morgan Stanley has set positive forward targets for the Hang Seng Index.
| Institution | Forecast Time Point | Hang Seng Index Target (Base Scenario) | Hang Seng Index Target (Bull Scenario) |
|---|---|---|---|
| Morgan Stanley | End of December 2026 | 27,500 points | 34,700 points |
In this context, technology stocks become the core driver of the market. At the same time, the recovery of cyclical sectors and the defensive value of high-dividend assets also provide diversified investment opportunities, jointly forming a professional investment landscape full of opportunities and challenges.
Abundant capital is the cornerstone driving a bull market. Looking ahead to 2026, the liquidity environment for the Hong Kong stock market is expected to significantly improve under the combined effect of multiple positive factors, providing solid support for market upside.
The market widely expects major global central banks, especially the Federal Reserve, to enter an interest rate cutting cycle between 2025 and 2026. The shift in the interest rate environment will ease funding pressures in global markets and release substantial liquidity. For an open economy like Hong Kong, improved USD liquidity will directly reduce financing costs and attract international capital inflows.
Mainland China’s continuous rollout of steady growth policies has injected a strong boost into the market. The government has clearly stated that it will adopt an expansionary fiscal stance in 2025, supplemented by multiple specific measures to boost economic vitality.
The implementation of these policies will effectively improve corporate profit expectations and enhance investor confidence.
Southbound capital from mainland China has become a key force influencing the Hong Kong stock market. Data shows that since July 2023, southbound capital has achieved net inflows for 27 consecutive months. As of early September 2025, the net inflow scale for the year has exceeded HK$1.006 trillion, setting a historical record. This force has significantly strengthened its pricing power in core assets, especially in the technology sector.
After prolonged adjustments, the valuation depression effect of Hong Kong stocks has become more prominent, attracting global long-term investors for reallocation.
The valuation level of the Hang Seng Index provides a safety margin. As of December 2025, its price-to-earnings ratio (PE) is 18.08 times, although higher than the past decade’s average of 15.16 times, it remains attractive globally.
As mainland China’s economy stabilizes and global risk appetite recovers, foreign capital is expected to reverse previous sustained outflows and redirect attention to high-quality Chinese assets with long-term growth potential.

Image Source: pexels
If capital is water, then corporate profits are the boat. Profit growth is the core engine driving the long-term bull market in the Hong Kong stock market. Looking ahead to 2026, under the backdrop of AI technology empowerment and global economic recovery, the profit fundamentals of listed companies are expected to see significant improvement.
Artificial intelligence is becoming key for tech giants to unlock their second growth curve. Progress in AI business directly impacts market judgments of company value. For example, a Nasdaq report noted that after news of Baidu potentially spinning off its Kunlun AI chip unit for an IPO, its stock price rose about 10%, and Citibank reaffirmed its $181 target price.
Broader research indicates that AI applications can fundamentally enhance corporate value.
A study of Chinese A-share listed companies from 2015 to 2023 found that AI technology significantly improves corporate ESG (environmental, social, and governance) performance through the following ways:
- Alleviating financing constraints
- Enhancing external oversight
- Improving information disclosure
This technology-driven efficiency and governance optimization provides a solid foundation for long-term corporate growth.
After challenges in previous years, many companies have gradually emerged from the trough through cost reduction and efficiency gains, with profitability beginning to recover. Data shows that profit margins for Hong Kong non-financial stocks improved by 0.3 percentage points year-on-year in the first half of this year. More importantly, the market holds positive expectations for future profit growth, with the consensus EPS growth forecast for the Hang Seng Index in 2026 reaching 10%, indicating that the profit inflection point has been established.
As the global economy gradually recovers, demand for industrial goods is expected to rebound, bringing significant profit elasticity to cyclical sectors. Taking copper as an example, as an economic “barometer,” its price forecasts reflect market optimism. Multiple institutions predict that copper prices will remain high in 2025-2026, with some forecasts even suggesting a potential breakthrough above $10,000 per ton.
| Institution/Source | 2025 Average Copper Price Forecast | 2026 Average Copper Price Forecast |
|---|---|---|
| ING Think | $9,572 per metric ton | $9,837 per metric ton |
| Scotiabank | $4.25 per pound | $4.05 per pound |
| Gov Capital | Near $5.60 per pound by end of 2025 | $5.10-5.70 per pound |
New demands from energy transition and data centers will continue to absorb copper supply, creating a favorable operating environment for companies in related industrial, energy, and materials sectors.
The “offshore licensing” of Chinese innovative drug companies is becoming a highly certain growth path, driving sector value revaluation. Multinational pharma companies have generally recognized the quality of Chinese innovative drug assets, with BD transactions (Business Development) becoming increasingly active.
This trend indicates that Chinese innovative drug companies are leveraging their R&D strength to secure a place in the global market, with their intrinsic value being rediscovered and repriced by international capital.
Although the market expects a bull market pattern, investors have significant divergences on the sources of driving forces, macroeconomic constraints, and the ultimate market form. These divergences form the investment backdrop under cautious expectations, highlighting the importance of structural opportunities.
The market holds two different views on the core driver of this rally. Some institutions believe valuation repair is the main driver. For example, HSBC Private Bank is bullish on Hong Kong stocks due to attractive valuations and high dividend yields. This view holds that current low prices provide sufficient upside space.
However, another perspective emphasizes that only solid profit growth can support a sustainable bull market. They argue that rallies relying solely on valuation expansion are short-lived, and companies must prove their profitability is entering an upward channel to truly earn long-term capital trust.
Global liquidity expectations are positive, but mainland China’s credit cycle may exhibit oscillations and slowdown. This means weaker credit expansion willingness in corporate and household sectors, constraining the intensity of fixed asset investment and consumption recovery.
Slowdown in credit expansion may limit capital expenditure and growth speed in some industries. This will make the overall market upside slope gentler, rather than a V-shaped reversal.
Under global rate cut expectations, the market will welcome abundant “excess liquidity.” These funds will actively seek “scarce assets” with high growth certainty and long-term competitive barriers. In the current environment, such assets mainly point to:
This game will lead to significant internal market differentiation, with valuation premiums for high-quality assets potentially continuing to widen.
Overall, the market is forming a clear consensus: the 2026 rally will primarily feature structural characteristics rather than a broad rise. Investors need to abandon the fantasy of “rising tide lifts all boats” and focus on specific sectors and companies that can transcend cycles and realize growth logic. The ability to select individual stocks will become key to determining investment returns.

Image Source: pexels
Facing the structural bull market pattern in 2026, the core of investment strategy lies in precisely identifying and focusing on sectors with long-term growth momentum. Investors should abandon broad rally expectations, adopt a selective approach, and allocate around four main lines: AI technology, innovative growth, stable high dividends, and cyclical elasticity.
Artificial intelligence is the core engine driving this bull market, with investment opportunities spanning hardware and application levels.
On the hardware side, the explosion in AI computing power demand brings certain growth to the industry chain. Demand for key components like neural processing units (NPU) and high-bandwidth memory (HBM) is particularly strong. Data shows these sub-markets are entering a high-growth period.
| AI Hardware Sub-Market | Expected Compound Annual Growth Rate (2025-2034) |
|---|---|
| Neural Processing Unit (NPU) | Over 19% |
| High-Bandwidth Memory (HBM) | Over 19% |
| Graphics Processing Unit (GPU) | Over 18% |
| AI-Optimized DRAM | Over 18% |
NPU growth mainly benefits from its low-latency and high-efficiency advantages in edge device AI applications. Meanwhile, AI-optimized DRAM is expected to see significant market adoption growth through supporting rapid data exchange in training processes.
On the application side, commercialization progress in fields like autonomous driving is accelerating, providing huge growth space for related companies. Some companies planning to list in Hong Kong have demonstrated strong technical strength and commercialization potential.
Industry expert Le noted that Pony AI and WeRide are “among global leaders”, highlighting their technology moats and investment value.
Beyond AI, innovative drug companies and consumer brands with global competitiveness represent another important growth line in the Hong Kong stock market.
Chinese innovative drug companies are achieving value revaluation through the “offshore licensing” model. Sichuan Biokin focuses on developing ADC drugs for cancer treatment, with 17 therapies in its pipeline and a co-development agreement with Bristol Myers Squibb. Rona Therapeutics, planning to list, focuses on RNA interference therapies with 15 drug pipelines.
Henlius Biopharmaceutical stands out among them. The company has built stable cash flows through biosimilars to fund innovative drug R&D. In the first half of 2024, total revenue was approximately $389 million, with net profit reaching $54 million. Its flagship PD-1 inhibitor serplulimab achieved breakthroughs in small cell lung cancer treatment, with expected global peak sales of $5 billion, and has begun contributing significant growth in overseas markets like Southeast Asia and India.
Additionally, more mainland Chinese consumer brands are accelerating global expansion through “A+H” dual listings on the Hong Kong Stock Exchange. Listings of seasoning manufacturers like Haitan Flavoring indicate Chinese brands are actively participating in international competition, providing investors opportunities to share globalization dividends.
In market volatility, high-dividend assets provide valuable defensiveness and stable cash returns, serving as the “ballast stone” in investment portfolios. Such assets are mainly concentrated in state-owned enterprises in mature industries like finance, energy, and telecommunications, with stable operations and consistent payout policies.
The performance of the Hang Seng High Dividend Yield Index fully illustrates the attractiveness of such assets.
| Indicator | Value |
|---|---|
| Underlying Index | Hang Seng High Dividend Yield Index |
| Annualized Yield | 6.25% (as of December 9, 2025) |
| Per Share Dividend | Approximately $0.21 (calculated at HK$1.60) |
For long-term investors seeking stable returns, allocating to high-dividend assets not only yields considerable dividend income but also acts as a buffer when market uncertainty increases.
As the global economy recovers, cyclical sectors like industrial, energy, and materials will exhibit significant profit elasticity.
In the industrial and materials field, the lithium battery industry chain is a focus worth attention. Benefiting from strong demand in new energy vehicles and energy storage markets, industry prospects are broad.
In the energy field, despite the global shift to green energy, traditional energy will still play an important role in the coming years. Price forecasts indicate oil and gas prices will remain at levels enabling corporate profitability.
| Energy Type | Forecast Price (2026) |
|---|---|
| Brent Crude | $55 per barrel |
| Henry Hub Natural Gas | $4 per million British thermal units (BTUs) |
This price environment provides stable profit expectations for energy giants like CNOOC and PetroChina, making them important investment targets in cyclical recovery.
Looking ahead to 2026, the Hong Kong stock market, under the resonance of AI technology and industrial recovery, presents a structural bull market pattern. Key investment directions are clear: AI technology as the main line, supplemented by innovative pharmaceuticals and high-dividend assets, while paying attention to phased opportunities in cyclical sectors.
Risk Disclosure Investors must remain prudent and face potential risks:
- Uncertainties in global macroeconomic policies, especially the Federal Reserve’s interest rate path.
- Impacts from slowdown in mainland China’s credit cycle.
- AI Bubble Risk: Studies show AI bubble risk scored 8 out of 8, with highly concentrated investments; if technology promises fail to materialize, it could trigger chain reactions.
The bull market pattern in the Hong Kong stock market in 2026 is mainly driven by two factors:
Market consensus believes this is not a broad rally. The bull market will exhibit significant “structural” features. Capital will concentrate in “scarce assets” with core competitiveness, such as AI leaders and innovative drug companies. Investors need to select individual stocks rather than expect all stocks to rise.
Investors should be vigilant about several major risks. Global macroeconomic policies, especially the Federal Reserve’s interest rate path, carry uncertainties. Additionally, there may be bubble risks in the AI field. Studies show its bubble score is 8 out of 8, with highly concentrated investments, requiring caution against pullbacks.
Besides AI technology stocks as the core main line, several other sectors provide diversified opportunities. Innovative drug companies show growth potential through offshore capabilities. High-dividend state-owned enterprises provide stable defensive value. Cyclical industrial and energy sectors possess profit elasticity.
*This article is provided for general information purposes and does not constitute legal, tax or other professional advice from BiyaPay or its subsidiaries and its affiliates, and it is not intended as a substitute for obtaining advice from a financial advisor or any other professional.
We make no representations, warranties or warranties, express or implied, as to the accuracy, completeness or timeliness of the contents of this publication.



